Panacea Biotec

Generic Pharmaceutical Manufacturing Company

Panacea Biotec    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker registered in India with principal offices in New Delhi, Mumbai, and Lalru. Panacea Drugs Pvt. Ltd. was set up in the year 1984 and got listed in 1995 as Panacea Biotec Ltd. The company has grown organically to become one of the largest vaccine manufacturers in India. It has strong roots in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products. Russian Direct Investment Fund (RDIF) collaborated with Panacea Biotec to produce 'Sputnik V' Covid-19 vaccine in India.


You Might Like

Panacea Biotec supplies second component of Sputnik V vaccine in India

IndiaTimes - Published

Covid: One-dose Sputnik Light set for rollout in September

India’s immunisation plan against Covid-19 may get bolstered soon with the rollout of locally manufactured single-dose Sputnik Light in September. Panacea Biotec, which had earlier partnered Russian..
IndiaTimes - Published

Panacea Biotec to manufacture up to 25 million doses of Sputnik V vaccine

The company has entered into a "licensing and manufacturing agreement with Human Vaccine Limited Liability Company, a subsidiary of Russian Direct Investment Fund, Russia, Generium Joint Stock..
IndiaTimes - Published

Sputnik V vaccine production in India to go fully on stream in September: RDIF

The production of Sputnik V in India is expected to come fully on stream in September. "Production in India is expected to come fully onstream in September and RDIF expects India to become a major..
IndiaTimes - Published

COVID-19: Panacea Biotec, RDIF to start Sputnik V production in India

RDIF and Panacea have agreed to produce 100 million doses per year of Sputnik V.
DNA - Published

Seven Indian pharma players race to develop Covid-19 vaccine

At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already..
IndiaTimes - Published

Indian firm Panacea says aiming to make COVID-19 vaccine

Indian biotech firm Panacea Biotec Ltd said on Wednesday it would partner with U.S.-based Refana Inc to make a potential vaccine for COVID-19.
Reuters India - Published